Literature DB >> 2022993

Radiation absorbed dose calculations for samarium-153-EDTMP localized in bone.

J C Heggie1.   

Abstract

Calculations have been undertaken to estimate the likely radiation dose received by patients undergoing treatment with samarium-153-EDTMP. Previously known bone structure parameters have been employed to partition correctly the energy absorbed in the bone matrix between red bone marrow, yellow marrow, and various types of mineral bone. Both uniform surface and volume distribution of the radioactivity are considered. The key findings of the calculations can be stated in terms of the MIRD "S-factors" for red bone marrow and the endosteal layer of cells on bone surfaces. In particular, the S-factor for red bone marrow is either 0.0276 mGy/MBq.h or 0.0077 mGy/MBq.h for surface and volume distributed radioactivity, respectively. For the endosteal layer of thickness (10 microns) on bone surfaces, the corresponding values are 0.0723 mGy/MBq.h and 0.0213 mGy/MBq.h, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022993

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.

Authors:  Oliver Sartor
Journal:  Rev Urol       Date:  2004

Review 2.  153Sm-EDTMP for bone pain palliation in skeletal metastases.

Authors:  Carlo L Maini; Serenella Bergomi; Luisa Romano; Rosa Sciuto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236

3.  Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose.

Authors:  Eduardo Savio; Javier Gaudiano; Ana M Robles; Henia Balter; Andrea Paolino; Andrea López; Juan C Hermida; Eugenia De Marco; Graciela Martinez; Eduardo Osinaga; Furn F Knapp
Journal:  BMC Nucl Med       Date:  2001

4.  Comparative Therapeutic Efficacy of 153Sm-EDTMP and 177Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients' Pain Score Analysis and Personalized Dosimetry.

Authors:  Sarika Sharma; Baljinder Singh; Ashwani Koul; Bhagwant Rai Mittal
Journal:  Front Med (Lausanne)       Date:  2017-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.